ClinicalTrials.Veeva

Menu

Feasibility Trial for Detecting Drug-induced Respiratory Depression and Prompting for Self-rescue

Utah System of Higher Education (USHE) logo

Utah System of Higher Education (USHE)

Status

Completed

Conditions

Healthy

Treatments

Device: Prompting breaths via recorded voice, vibrating massager, and/or muscle tetany

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT02744599
R43NR015955 (U.S. NIH Grant/Contract)
IRB_00056695

Details and patient eligibility

About

This is a small trial to test feasibility of an idea for a potential device. The investigators tested the feasibility of prompting a volunteer to breathe when their breathing had slowed down during administration of anesthetic drugs.

Enrollment

26 patients

Sex

All

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • American Society of Anesthesia (ASA) Class I and Class II male and female (non-pregnant/non-lactating) volunteers.
  • Normal healthy individual as indicated by medical history and a physical examination.
  • At least 18 years of age and less than 55 years of age.
  • Negative drug screen.
  • Uncomplicated airway anatomy.
  • A Body Mass Index between 18 and 32.
  • Are fully informed of the risks of entering the study and willingly provide written consent to enter the trial.
  • Female subjects of child bearing potential will have a negative urine pregnancy test on the day the study is conducted.

Exclusion criteria

  • Known or suspected neurological pathologies.
  • A history of significant alcohol or drug abuse, a history of allergy to opioids or propofol, or a history of chronic drug requirement or medical illness that is known to alter the pharmacokinetics or pharmacodynamics of remifentanil and propofol.
  • Known obstructive sleep apnea.
  • Known or suspected hypersensitivity to any compound present in the study.
  • Any potential subject suffering from medical problems that, in the judgment of the investigator, presents unacceptable risk to the volunteer are not eligible for enrollment.
  • Vulnerable subject groups such as prisoners and the mentally disabled that are traditionally excluded from medical research are also excluded.
  • The potential subject has taken any medication within 2 days prior to chosen drug administration, with the exception of oral contraceptives.
  • The potential subject is wearing artificial nails.
  • A positive urine pregnancy test (females only)
  • Female subjects who are currently lactating & breast-feeding.
  • A positive drug-screening test.
  • The subject consumed food or fluids within 8 hours prior to start of each chosen drug administration.
  • Any medications or alcohol within 2 days prior to start of the chosen drug administration, with the exception of oral contraceptives.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

26 participants in 2 patient groups

Device prompting
Experimental group
Treatment:
Device: Prompting breaths via recorded voice, vibrating massager, and/or muscle tetany
Control
No Intervention group
Description:
Patients receive standard of care

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems